What the Shark Immune System Can and Cannot Provide for the Expanding Design Landscape of 1

What the Shark Immune System Can and Cannot Provide for the Expanding Design Landscape of 1

Review What the shark immune system can and cannot provide for the expanding design landscape of 1. Introduction: sharks and the evolution of immunity immunotherapy 2. What shark immunity cannot Michael F Criscitiello offer us: simple cancer cures Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, Texas A&M 3. What shark immunity can offer Health Science Center, Comparative Immunogenetics Laboratory, Department of Veterinary us: useful antigen receptor Pathobiology, College Station, TX, USA genetics and structure Introduction: 4. Sharks and the future of Sharks have successfully lived in marine ecosystems, often atop immunotherapeutics food chains as apex predators, for nearly one and a half billion years. Throughout this period they have benefitted from an immune system with 5. Conclusion the same fundamental components found in terrestrial vertebrates like 6. Expert opinion man. Additionally, sharks have some rather extraordinary immune mecha- nisms which mammals lack. Areas covered: In this review the author briefly orients the reader to sharks, their adaptive immunity, and their important phylogenetic position in comparative immunology. The author also differentiates some of the myths from facts concerning these animals, their cartilage, and cancer. From thereon, the author explores some of the more remarkable capabilities and products of shark lymphocytes. Sharks have an isotype of light chain-less antibodies that are useful tools in molecular biology and are moving towards translational use in the clinic. These special antibodies are just one of the several tricks of shark lymphocyte antigen receptor systems. Expert opinion: For personal use only. While shark cartilage has not helped oncology patients, shark immunoglobulins and T cell receptors do offer exciting novel possibilities for immunotherapeutics. Much of the clinical immunology developmental pipe- line has turned from traditional vaccines to passively delivered monoclonal antibody-based drugs for targeted depletion, activation, blocking and immu- nomodulation. The immunogenetic tools of shark lymphocytes, battle-tested since the dawn of our adaptive immune system, are well poised to expand the design landscape for the next generation of immunotherapy products. Keywords: antibody, antigen receptor, immunology, shark, T cell receptor Expert Opin. Drug Discov. Downloaded from informahealthcare.com by Texas A&M Univ on 07/18/14 Expert Opin. Drug Discov. (2014) 9(7):725-739 1. Introduction: sharks and the evolution of immunity 1.1 Sharks Nearly 450 species of shark have radiated to most marine and a few of the freshwater environments of our planet. They range from wee (the 7-inch dwarf lanternshark Etmopterus perryi) to mammoth (the 39-foot whale shark Rhincodon typus, the largest fish). They have keen olfaction and electroreception. They use diverse repro- ductive strategies that include oviparity, polyandry, viviparity and parthenogene- sis [1]. Sharks have many sets of replaceable teeth. Sharks are carnivores that collectively have evolved a variety of feeding strategies: filter-feeding, cooperative pack hunting, ambush sucking, cookie-cutting, ram feeding and protrusible jaw cat- apulsion. And yes, a very few species of shark have been involved in a small number of unprovoked, fatal attacks upon humans. These rare events created the popular 10.1517/17460441.2014.920818 © 2014 Informa UK, Ltd. ISSN 1746-0441, e-ISSN 1746-045X 725 All rights reserved: reproduction in whole or in part not permitted M. F. Criscitiello immune repertoire through immunization. Successful immuni- Article highlights. zation with attenuated virus, killed pathogen or irradiated can- . Sharks get cancer and shark cartilage is no cancer cer cell (or parts thereof) increases the frequency of antigen panacea. specific lymphocytes by several orders of magnitude. Therefore, . Cartilaginous fish (such as sharks) are the oldest group if the same antigen is seen again in the context of the actual path- of animals with the basic components of the vertebrate ogen or cancer, the kinetics, quality and amplitude of the adaptive immune system. Sharks employ a single-chain antibody isotype (two response is much better than it would be on first encounter heavy chains, no light chain) that have much utility. with the antigen. Ideally this memory effect from immunization . There are additional immunogenetic tricks available to will result in a secondary response upon challenge that will shark lymphocytes (single-variable domain T cell receptor provide both asymptomatic clearance and a dead end for an (TCR) binding, Ig/TCR trans-rearrangements and somatic infectious pathogen with no further spread in the population. hypermutation at TCR loci), which may be translationally useful. 1.3 The evolution of ‘our’ immune system This box summarizes key points contained in the article. All life has innate immune mechanisms, but adaptive immu- nity has for long been thought to be an innovation of vertebrate animals (Figure 2) [2]. Antigen challenge and allogeneic graft misconception of sharks as indiscriminate eating machines. experiments in lamprey [3], shark [4-6] and bony fish [7] Although far from certain, it is possible that the evolution of suggested that these species were capable of making antigen- their infamous Jaws may have been important in the genesis specific memory responses long before any molecular or of the adaptive immune system upon which most of our genetic mechanisms were elucidated. A wealth of data from global public health efforts are based. several model species suggests that many if not most of the fun- damental components of the adaptive immune system found 1.2 Adaptive immunity in mouse and man had evolved in our most recent common The adaptive immune system is distinguished from the innate ancestor with sharks [8]. As the shark adaptive immune system system it was built upon by its fine molecular specificity for is germane and central to the discussions of drug development antigen and memory for that specific antigen long after an that follows, our current knowledge of this system will be initial immune response. Lymphocytes are the cells that medi- briefly reviewed here. Much of this has been learned from the ate adaptive immunity: B cells making antibodies for humoral study of shark immunology, but also from the study of other immunity and T cells effecting cell-mediated immunity. The B cartilaginous fish such as skates and chimeras. Thus, I will For personal use only. and T lymphocytes develop in the primary lymphoid tissues, review these data too where appropriate. the thymus for T cells and (in humans) the bone marrow Those early graft and challenge studies gave way to for B cells. There they stochastically diversify the genes that biochemical and molecular work to determine many genes encode the antigen receptors on the cell surface. The antigen and proteins responsible for immune responses in these fish. receptors on any individual lymphocyte all have the same Primate and rodent immunologists would recognize many of antigen-binding structure based on the unique somatic cell the immune mechanisms of sharks. Innate immunity is fully gene rearrangements that occurred at the antigen receptor competent and includes lysozyme [9], acute phase proteins [10], loci (Figure 1). Vast repertoires of lymphocytes with distinct a complement system with tripartite activation pathways antigenic specificities circulate in the organism. A mature lym- [11-15], and nitric oxide production in leukocytes stimulated phocyte activated in the secondary lymphoid tissues (e.g., with pathogen associated molecular patterns [16]. Importantly, lymph node, spleen, Peyer’s patch) can then be clonally the adaptive immune system is just as well developed with mul- Expert Opin. Drug Discov. Downloaded from informahealthcare.com by Texas A&M Univ on 07/18/14 expanded, mobilizing an army of cells specific for a particular tiple Ig heavy chain isotypes (including IgM and IgD) [17,18], antigen. The mitotic lymphocyte expansion will retain the antibody multimerization by the joining (J) chain [19],four rare antigenic specificity encoded by the antigen receptor genes isotypes of Ig light chains (including l and k) [20-22], B cell + of the maternal activated cell. These cells will produce specific differentiation to Blimp-1 plasma cells [23], well-characterized antibody, kill virally infected cells, direct other immune cells to affinity maturation [24], Ig-mediated opsonization and cytotox- act and remove neoplastic cells all based on the specificity of icity [25], four TCR chains (a, b, g and d) [26,27], antigen recep- their antigen receptor. Some of the expanded lymphocyte tor signal transduction via accessory molecule immunoreceptor clones differentiate into long-lived memory cells that can tyrosine based activation motifs [28], polygenic and polymorphic greatly augment the quality and quantity of response to chal- major histocompatibility complex (MHC) Class I [29] and Class lenges by the same antigen in years or decades to come. II [30], b2-microglobulin genomically linked to the MHC [31], The hallmark characteristics of adaptive immunity (specific- MHC-linked immunoproteasome and peptide transport ity and memory) reside in the antigen receptors: the B cell recep- components [32], MHC Class II antigen processing employing tor (surface antibody or immunoglobulin [Ig]) and the T cell the invariant chain (Ii) [33] and phagolysosomal acid [34], the receptor (TCR). The specificity in the lymphocyte

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    15 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us